Catheter Precision, Inc. earnings per share and revenue
On Nov 13, 2025, VTAK reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.14 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 1.22 million, with a --% difference. The market reacted with a -5.36% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.11 USD, with revenue projected to reach 1.73 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
What were Catheter Precision, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Catheter Precision, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Catheter Precision, Inc.'s Q3 2025 earnings?
The stock price moved down -5.36%, changed from $2.05 before the earnings release to $1.94 the day after.
When is Catheter Precision, Inc. expected to report next?
The next earning report is scheduled for Mar 19, 2026.
What are the forecasts for Catheter Precision, Inc.'s next earnings report?
Based on 3
analysts, Catheter Precision, Inc. is expected to report EPS of -$0.11 and revenue of $1.73M for Q4 2025.